drugset / Trial / NCT03372044

A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects

NCT03372044

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

An open-label study to understand the effect of different modified release and immediate release formulations on plasma PF-06865571 concentrations after single oral administration under fed conditions

Timeline

Start
2018-01-19
Primary completion
2018-03-09
Completion
2018-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06865571 Small molecule Oral

Indications

No indication recorded.